2019
DOI: 10.1016/j.celrep.2019.01.024
|View full text |Cite
|
Sign up to set email alerts
|

sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing

Abstract: SummaryCas9 nucleases can be programmed with single guide RNAs (sgRNAs) to mediate gene editing. High CRISPR/Cas9-mediated gene knockout efficiencies are essential for genetic screens and critically depend on the properties of the sgRNAs used. The specificity of an sgRNA is defined by its targeting sequence. Here, we discovered that two short sequence motifs at the 3′ end of the targeting sequence are almost exclusively present in inefficient sgRNAs of published sgRNA-activity datasets. By specific knock-in of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

7
107
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 101 publications
(117 citation statements)
references
References 18 publications
7
107
1
Order By: Relevance
“…The sgRNA simplifies the assembly of the ribonuclear protein (RNP) complex as well as the transcription of the gRNA from a delivered plasmid. Essential parts of the sgRNA have been investigated and many studies have been carried out to optimize the sgRNA sequence . However, for therapeutic applications of the CRISPR/Cas9 system that involve delivery of an intact RNP, chemical modifications of the sgRNA will be required, similar to other existing therapeutic oligonucleotides (i.e., antisense oligonucleotides, siRNAs) .…”
Section: Introductionmentioning
confidence: 99%
“…The sgRNA simplifies the assembly of the ribonuclear protein (RNP) complex as well as the transcription of the gRNA from a delivered plasmid. Essential parts of the sgRNA have been investigated and many studies have been carried out to optimize the sgRNA sequence . However, for therapeutic applications of the CRISPR/Cas9 system that involve delivery of an intact RNP, chemical modifications of the sgRNA will be required, similar to other existing therapeutic oligonucleotides (i.e., antisense oligonucleotides, siRNAs) .…”
Section: Introductionmentioning
confidence: 99%
“…The observation that no editing activity was detected at the StGBSSI target locus for both spacer lengths (sgRNA1 and 3) may be due to the presence of an inefficient motif in the spacer sequence. However, none of the two motifs identified as inefficient in a previous study [20] was present in our spacer sequences, suggesting another origin for the lack of editing at this locus, such as the genomic context that may interfere with Cas9 binding and cleavage, and pointing out to the necessity to test independent spacer sequences for a target gene in order to maximize the likelihood of successful editing. Based on manual analysis of the chromatograms for sgRNA2 and 4 (StDMR6-1 locus), we found that frameshift mutations mostly occurred about 4-bp upstream of the PAM sequence ( Fig 2B), as previously reported for SaCas9 [11,12].…”
Section: Crispr-sacas9-mediated Gene Editing Of the Potato Genomementioning
confidence: 60%
“…For our simulations, we used the decile of GC content for each sgRNA's template guide. Users may also derive a sgRNA categorical feature through an efficiency score formula such as those developed in (24,(31)(32)(33)(34)(35). Guide efficiency g is derived from fitting weight ω f to the feature category F g of guide g:…”
Section: Methodsmentioning
confidence: 99%